openPR Logo
Press release

Neuropathic Pain Market Opportunities and Market Segmentation Insights: 2024 to 2030

Neuropathic Pain Market

Neuropathic Pain Market

The global neuropathic pain market, valued at USD 8.13 billion in 2023, is projected to reach USD 11.91 billion by 2030, growing at a CAGR of 5.6%. The rise in chronic diseases such as diabetes, multiple sclerosis, and neurological conditions continues to fuel the market growth. Additionally, the increasing focus on advanced pharmacological and non-pharmacological treatments, including novel drug therapies, is expected to drive demand across global markets.

๐†๐ž๐ญ ๐š ๐œ๐ฅ๐จ๐ฌ๐ž๐ซ ๐ฅ๐จ๐จ๐ค ๐š๐ญ ๐ญ๐ก๐ž ๐ ๐š๐ฆ๐ž-๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฌ๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ :https://www.maximizemarketresearch.com/request-sample/34992/

๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ

Vietnam is seeing a rise in chronic conditions like diabetes, which has led to an increased need for neuropathic pain treatments. ๐๐Ÿ๐ข๐ณ๐ž๐ซ and ๐๐š๐ฒ๐ž๐ซ are looking to expand their presence in the region, offering advanced treatments for neuropathic pain management.

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐

Thailand's growing elderly population is driving the demand for neuropathic pain solutions. With increasing awareness and healthcare investment, the market is expected to continue evolving, with more companies like ๐๐จ๐ฏ๐š๐ซ๐ญ๐ข๐ฌ focusing on localizing treatment options to meet the needs of the population.

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง

Japan has one of the world's highest elderly populations, contributing to a significant demand for neuropathic pain therapies. Recent mergers, such as ๐“๐š๐ค๐ž๐๐š ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ'๐ฌ acquisition of ๐“๐ข๐†๐ž๐ง๐ข๐ฑ, highlight the country's increasing focus on pain management solutions tailored to the elderly.

๐”๐ง๐ฅ๐จ๐œ๐ค ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ž๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ฏ๐ข๐š ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/34992/

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‚๐ก๐ข๐ง๐š

China's growing healthcare market has seen consolidation, as major players like ๐‡๐ข๐ค๐ฆ๐š ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ and ๐‚๐ข๐ฉ๐ฅ๐š enter the competitive field of neuropathic pain treatment. The government's push for more comprehensive healthcare coverage is expected to propel market growth further.

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š

With a fast-growing elderly population and a focus on healthcare innovation, South Korea is seeing rising demand for advanced neuropathic pain management. The country is benefiting from more investment in R&D for novel therapies and increased government spending on healthcare infrastructure.

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž

Singapore's growing role as a regional healthcare hub, coupled with its advanced research and clinical trial activities, is driving the demand for new treatments. The government is supporting the development of more effective pain management solutions to cater to the growing elderly population.

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ

The U.S. remains the largest market for neuropathic pain treatments, with the increasing incidence of chronic pain driving demand. The country is seeing significant shifts toward non-opioid therapies and the development of new drugs to address the opioid crisis, with major companies such as ๐‰๐จ๐ก๐ง๐ฌ๐จ๐ง & ๐‰๐จ๐ก๐ง๐ฌ๐จ๐ง investing heavily in R&D.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐๐š๐ญ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ฏ๐ข๐ž๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž @https://www.maximizemarketresearch.com/request-sample/34992/

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž

Europe's aging population and increasing chronic disease prevalence are driving demand for innovative neuropathic pain treatments. The region also benefits from advancements in pain relief technologies, with companies like ๐„๐ฅ๐ข ๐‹๐ข๐ฅ๐ฅ๐ฒ and ๐๐จ๐ฏ๐š๐ซ๐ญ๐ข๐ฌ investing in the development of next-generation pain relief therapies.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐›๐ฒ ๐ƒ๐ซ๐ฎ๐  ๐‚๐ฅ๐š๐ฌ๐ฌ

Antidepressants
Anticonvulsant
Opioids
Capsaicin
Others

The market is divided into categories such as capsaicin, opioids, antidepressants, anticonvulsants, and others. The market for neuropathic pain was dominated by the anticonvulsant segment in 2023 and is anticipated to continue to do so during the forecast period. The anticonvulsant section of the neuropathic pain market consists of a class of drugs that are mainly given to treat epilepsy, or seizures, but are also frequently used to treat neuropathic pain. Anticonvulsants, sometimes referred to as antiepileptic medications (AEDs), work by adjusting the central nervous system's neurotransmitter activity and neuronal excitability.

๐›๐ฒ ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง

Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-Induced Peripheral Neuropathy
Others

Diabetic neuropathy, spinal stenosis, chemotherapy-induced peripheral neuropathy, and others are the market segments. The market for neuropathic pain was dominated by the diabetic neuropathy category in 2023 and is anticipated to continue to do so during the forecast period. Within the larger neuropathic pain market, diabetic neuropathy is a subset that focuses on neuropathic pain disorders that develop as a result of diabetes mellitus. In people with diabetes, diabetic neuropathy is the term used to describe nerve damage brought on by extended exposure to elevated blood sugar levels (hyperglycemia). Sensory abnormalities and neuropathic pain are indications of nerve injury that can appear in different regions of the body.

๐›๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ

Hospital Pharmacies
Drugs Stores and Retail Pharmacies
Online Pharmacies

๐†๐ž๐ญ ๐š ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:https://www.maximizemarketresearch.com/market-report/global-neuropathic-pain-market/34992/

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š:
1. Pfizer Inc. - New York, United States
2. Eli Lilly and Company - Indianapolis, United States
3. Johnson & Johnson - New Brunswick, United States
4. Teva Pharmaceutical Industries Ltd. - Tel Aviv, Israel
5. Purdue Pharma - Stamford, United States
6. Endo Pharmaceuticals Inc. - Dublin, Ireland
7. AbbVie Inc. - North Chicago, United States
8. Mallinckrodt Pharmaceuticals - Staines-upon-Thames, United Kingdom
9. Biogen Inc. - Cambridge, United States

๐„๐ฎ๐ซ๐จ๐ฉ๐ž:
10. GlaxoSmithKline plc - Brentford, United Kingdom
11. Novartis AG - Basel, Switzerland
12. AstraZeneca plc - Cambridge, United Kingdom
13. Bayer AG - Leverkusen, Germany
14. Merck KGaA - Darmstadt, Germany
15. Boehringer Ingelheim - Ingelheim am Rhein, Germany
16. Sanofi - Paris, France
17. UCB S.A. - Brussels, Belgium
18. Ipsen Pharma - Paris, France
19. Grรผnenthal GmbH - Aachen, Germany

๐€๐ฌ๐ข๐š ๐๐š๐œ๐ข๐Ÿ๐ข๐œ:
20. Takeda Pharmaceutical Company Limited - Tokyo, Japan
21. Eisai Co., Ltd. - Tokyo, Japan
22. Astellas Pharma Inc. - Tokyo, Japan
23. Otsuka Holdings Co., Ltd. - Tokyo, Japan
24. Mitsubishi Tanabe Pharma Corporation - Osaka, Japan

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐Ÿ๐ญ๐ฌ :

โ™ฆ Global Smoked Fish Market https://www.maximizemarketresearch.com/market-report/global-smoked-fish-market/147525/

โ™ฆ Irish Whiskey Market https://www.maximizemarketresearch.com/market-report/global-irish-whiskey-market/94141/

โ™ฆ India lithium-ion battery market https://www.maximizemarketresearch.com/market-report/india-lithium-ion-battery-market/29994/

โ™ฆ Walnut Market https://www.maximizemarketresearch.com/market-report/global-walnut-market/24016/

โ™ฆ Saccharin Market https://www.maximizemarketresearch.com/market-report/saccharin-market/188060/

โ™ฆ Starch Market https://www.maximizemarketresearch.com/market-report/global-starch-market/112948/

โ™ฆ Hose Reel Market https://www.maximizemarketresearch.com/market-report/hose-reel-market/78645/

โ™ฆ Corundum Market https://www.maximizemarketresearch.com/market-report/corundum-market/148451/

โ™ฆ Global Cesium Market https://www.maximizemarketresearch.com/market-report/global-cesium-market/89395/

โ™ฆ Global Automotive Electric Oil Pump Market https://www.maximizemarketresearch.com/market-report/global-automotive-electric-oil-pump-market/35711/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market Opportunities and Market Segmentation Insights: 2024 to 2030 here

News-ID: 3809305 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR - Clinical Trials Market Forecast Insights
Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR โ€ฆ
According to a new report by Maximize Market Research, the global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032, growing at a CAGR of 6.13%. A major surge in biopharmaceutical R&D and oncology-focused studies is driving the global clinical trials market toward nearly USD 88.26 billion by 2032 at a 6.13% CAGR. โ–บ Get a sample of theโ€ฆ
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5.16% Driven
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5 โ€ฆ
Turbo Trainer Market size was valued at USD 281.52 Mn. in 2024 and the total Turbo Trainer revenue is expected to grow at 5.16% through 2025 to 2032, reaching nearly USD 421.03 Mn. Turbo Trainer Market Overview: The Turbo Trainer Market is witnessing significant growth as fitness enthusiasts increasingly adopt indoor cycling equipment for year-round training. Turbo trainers, which allow users to convert regular bicycles into stationary exercise machines, have become essentialโ€ฆ
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of 7% Driven
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of โ€ฆ
Sodium Acetate Market size was valued at USD 206.17 Million in 2024, and the total revenue is expected to grow at CAGR of 7 % from 2025 to 2032, reaching nearly USD 354.24 Million. Sodium Acetate Market Overview: The Sodium Acetate Market is experiencing steady growth due to its widespread applications across industries such as food and beverage, pharmaceuticals, textiles, and chemical manufacturing. Sodium acetate, a versatile salt of acetic acid, isโ€ฆ
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR -
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR - "India Tire โ€ฆ
According to a new report by Maximize Market Research, the India tire market was valued at approximately USD 13.4 billion in 2024 and is expected to climb to USD 27.6 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.6 %. The growth is underpinned by increasing automotive production, growing replacement demand, and rising adoption of radial tyres. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/21022/ โ™ฆ Key Highlights Market sizeโ€ฆ

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ